---
schema_version: "secwatch.filing_event.v1"
accession: "0000898432-22-000500"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2022-07-29T23:59:59+00:00"
generated_at: "2026-06-24T06:51:16.124709+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# iRadimed reports record Q2 revenue of $12.7M; GAAP EPS $0.26; full-year guidance raised

## Summary
- Q2 revenue $12.7M vs $9.8M YoY (+30%); GAAP diluted EPS $0.26 vs $0.12; non-GAAP EPS $0.26.
- Q3 2022 guidance: revenue $13.1-13.3M, GAAP EPS $0.21-0.24, non-GAAP EPS $0.22-0.25.
- Full-year 2022 guidance raised: revenue $52.5-53.2M (from $51.4-52.2M), GAAP EPS $0.89-0.95 (from $0.82-0.90), non-GAAP EPS $0.96-1.03.
- Gross margin improved to 79.7% from 76.2%; domestic sales 85% of revenue.
- Q2 cash from operations $1.6M vs $3.6M YoY; orders exceeded shipments building backlog.

## SEC filing metadata
- accession: 0000898432-22-000500
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2022-07-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000089843222000500/0000898432-22-000500-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000089843222000500/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000898432-22-000500
- JSON: https://secwatch.observer/filing/0000898432-22-000500.json
- Plain text: https://secwatch.observer/filing/0000898432-22-000500.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.